glp-1 in psych patients Thinking about taking a med (e.g., Ozempic)? Share your experience with researchers We are exploring the psychological effects of taking a GLP- 1 medication and are currently seeking participants who are thinking Updates on GLP-1 Receptor Agonists

GLP-1 Rx Program (Compounded Medications) Trial: $149 for the first 21 days After trial: $837 for 12 weeks (about $279 per month) Medication is included in the price Compounded and generic GLP-1 medications shipped to your door Not available in Alabama, Louisiana, or Mississippi Microdose GLP-1 Rx Program Trial: $119 for the first 21 days After trial: $597 for 12 weeks (about $199 per month) Medication is included in the price Lower dose of compounded semaglutide than the standard plan Same state restrictions as the GLP-1 Rx Program GLP-1 Rx Program (Telehealth for Branded Meds) Trial: $69 for the first month After trial: $297 for 3 months (about $99 per month) Medication is NOT included Clinicians may prescribe Wegovy or Zepbound You fill the prescription at your own pharmacy Not available in Alabama or Virginia Proactive Health Microdose GLP-1 Rx Program $149 per month Low-dose GLP-1 combined with biomarker monitoring Includes personalized feedback on health markers Figure 1: Monthly program costs across Noom Med plans and competitors TIP The branded meds plan looks cheapest at $99 per month, but you still need to pay for the actual medication

If you pay out of pocket, the lowest dose of Foundayo costs $149 a month, which is about half the price of the cheapest version of Zepbound

but lower doses led to more modest weight loss:Lower doses had a more favourable side effect profile, too:This triple agonism aims to relieve some of the side effects of GLP1s (nausea, muscle loss), and increase weight loss (so the dose can be lowered)Sources: New obesity drugs - nature.com/articles/d4158 Triple agonist Retatrutide phase 2 trial - nejm.org/doi/full/10.10 full article: openread.academy/en/paper/readi Breakdown of the article: The article discusses the development of new obesity drugs that aim to provide greater and healthier weight loss

Moreover, theranostic liposomes, which co-deliver drugs and imaging agents, have been developed to enable simultaneous therapy and real-time monitoring [121]